A novel CCR5 mutation selectively affects immunoreactivity and fusogenic property of the HIV co-receptor

AIDS

Volumn 18, Issue 12, 2004, Pages 1729-1732

  Zhao, Xiu Ying ^a   Lee, Shui Shan ^b   Wong, Ka Hing ^b   Chan, Kenny Chi Wai ^b   He, Zhi Min ^a   Ma, Selene ^a   Ng, Fai ^a   Chan, Chris Chung Sing ^a   Ho, Tina ^a   Ng, Mun Hon ^a   Zheng, Bo Jian ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b DEPARTMENT OF HEALTH   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; COTRIMOXAZOLE; PHENYLALANINE; VIRUS RECEPTOR;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CASE REPORT; DISEASE COURSE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOREACTIVITY; MALE; OPEN READING FRAME; PNEUMOCYSTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; VIRUS MUTATION;

AMINO ACID SEQUENCE; HETEROZYGOTE; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, HIV; RNA, MESSENGER; RNA, VIRAL; SEQUENCE DELETION;

EID: 4143116692     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000131382.15232.dc     Document Type: Article

References (7)

1. Zheng BJ, Zhao XY, Zhu NS, Chan CP, Wong KH, Chan CW, et al. Polymorphism of CCR5 gene in a southern Chinese population and their effects on disease progression in HIV infections. AIDS 2001, 16:2480-2482.
2. Chou ST, Ladiges WC. Detection of transgene product in mouse peripheral blood lymphocytes: a minimally invasive microassay. Comp Med 2002, 52:543-547.
3. Dey B, Berger EA. Vaccinia-based reporter gene cell-fusion assay to quantitate functional interactions of HIV envelope glycoprotein with receptors. Curr Protocols Immunol 2003; 12.10.1-12.10.20.
4. Wu LJ, LaRosa G, Kassam N, Gordon CJ, Heath H, Ruffing N, et al. Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med 1997, 186:1373-1381.
5. Olson WC, Rabut CE, Nagashima KA, Tran DN, Anselma DJ, Monard SP, et al. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5. J Virol 1999, 73:4145-4155.
6. Broder CC, Berger EA. Fusiongenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type I tropism for CD4+ T-cell links vs. primary macrophages. Proc Natl Acad Sci USA 1995, 92:9004-9008.
7. Lee B, Sharron M, Blanpain C, Doranz BJ, Vakili J, Setoh P, et al. Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function. J Biol Chem 1999, 274:9617-9626.